We are live on ! Find out more
Ameriprise

Ameriprise Portfolio holdings

AUM $432B
1-Year Est. Return 30.22%
 

Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.

This Fund
S&P 500
This Quarter Est. Return
+16.44%
1 Year Est. Return
+30.22%
3 Year Est. Return
+89.37%
5 Year Est. Return
+112.58%
10 Year Est. Return
+443.56%
AUM
$282B
AUM Growth
+$36.1B
Cap. Flow
+$663M
Cap. Flow %
0.24%
Top 10 Hldgs %
15.64%
Holding
3,918
New
198
Increased
1,664
Reduced
1,807
Closed
165

Top Buys

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$342M
2
ICE icon
Intercontinental Exchange
ICE
+$284M
3
DE icon
Deere & Co
DE
+$255M
4
BLK icon
Blackrock
BLK
+$248M
5
NEM icon
Newmont
NEM
+$243M

Sector Composition

Rank Sector Weight
1 Technology 23.84%
2 Healthcare 11.43%
3 Financials 11.03%
4 Consumer Discretionary 8.66%
5 Industrials 8.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AKBA icon
3676
Akebia Therapeutics
AKBA
$362M
$49K ﹤0.01%
17,479
+421
+2% +$1.23K
XERS icon
3677
Xeris Biopharma Holdings
XERS
$1.45B
$49K ﹤0.01%
10,015
-7,095
-41% -$35.5K
ATRS
3678
DELISTED
Antares Pharma, Inc.
ATRS
$48K ﹤0.01%
12,000
-2,500
-17% -$8.09K
LPTH icon
3679
Lightpath Technologies
LPTH
$648M
$47K ﹤0.01%
11,951
-190,757
-94% -$550K
ELVT
3680
DELISTED
Elevate Credit, Inc.
ELVT
$46K ﹤0.01%
11,504
-5,581
-33% -$16.4K
ADMA icon
3681
ADMA Biologics
ADMA
$2.01B
$44K ﹤0.01%
21,400
-27,280
-56% -$57.3K
VATE icon
3682
INNOVATE Corp
VATE
$111M
$43K ﹤0.01%
1,330
AGEN
3683
Agenus
AGEN
$329M
$39K ﹤0.01%
618
-6
-1% -$445
CPRX
3684
DELISTED
Catalyst Pharmaceutical
CPRX
$37K ﹤0.01%
10,955
-17,911
-62% -$60.2K
IAG icon
3685
IAMGOLD
IAG
$8.42B
$37K ﹤0.01%
10,000
XXII
3686
22nd Century Group
XXII
$1.34M
0
INFI
3687
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$35K ﹤0.01%
16,400
DRRX
3688
DELISTED
DURECT Corp
DRRX
$27K ﹤0.01%
1,291
-390
-23% -$7.42K
KOPN icon
3689
Kopin
KOPN
$663M
$27K ﹤0.01%
11,000
MCHX icon
3690
Marchex
MCHX
$78M
$26K ﹤0.01%
13,395
PTN
3691
Palatin Technologies
PTN
$13.9M
$26K ﹤0.01%
+31
New +$17.7K
SEAC
3692
DELISTED
Seachange International Inc
SEAC
$26K ﹤0.01%
930
-2,599
-74% -$45.1K
OGI
3693
Organigram Holdings
OGI
$136M
$23K ﹤0.01%
4,343
-749
-15% -$3.84K
CARM
3694
DELISTED
Carisma Therapeutics
CARM
$22K ﹤0.01%
+806
New +$20.4K
CRBP icon
3695
Corbus Pharmaceuticals
CRBP
$168M
$21K ﹤0.01%
575
-1,123
-66% -$42K
AUMN
3696
DELISTED
Golden Minerals Company
AUMN
$19K ﹤0.01%
1,006
SENS icon
3697
Senseonics Holdings Inc
SENS
$265M
$14K ﹤0.01%
810
XPL icon
3698
Solitario Resources
XPL
$67.5M
$11K ﹤0.01%
20,000
CATX icon
3699
Perspective Therapeutics
CATX
$341M
$9K ﹤0.01%
+2,000
New +$8.84K
AIG.WS
3700
DELISTED
American International Group, Inc.
AIG.WS
$5K ﹤0.01%
44,527
-21,688
-33% -$10.3K

Similar funds

Ameriprise's Q4 2020 Portfolio in Review

As of Q4 2020, Ameriprise held 3,918 positions worth $282B, up 15% from $246B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Ameriprise's Q4 2020 filing shows 198 new, 1,664 increased, 1,807 reduced and 165 closed positions. Its largest new stake was Array Technologies: 1,865,836 shares worth $80.5M. The largest sale was Apple, an estimated $638M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

  • Ameriprise's largest Q4 2020 buy was Array Technologies: 1,865,836 shares worth $80.5M.
  • Ameriprise added most to Morgan Stanley in Q4 2020, an estimated $342M increase.
  • Ameriprise's biggest Q4 2020 reduction was Apple, cutting an estimated $638M.
  • Ameriprise fully exited Immunomedics Inc in Q4 2020, selling an estimated $149M.
  • Ameriprise's ten largest holdings make up 16% of its $282B portfolio in Q4 2020.
  • Ameriprise opened 198 new positions and closed 165 in Q4 2020.
  • Ameriprise's portfolio value rose 15% quarter-over-quarter to $282B.

Based on Ameriprise's 13F filing for Q4 2020, filed 12 Feb 2021.